Monthly News Roundup - December 2023

Landmark FDA Approval for Casgevy, a CRISPR-Based Therapy for Sickle Cell Disease  This past month the U.S. Food and Drug Administration (FDA) cleared Casgevy (exagamglogene autotemcel), the first approved CRISPR/Cas9 genome-edited cell...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news